Droller Michael J
The Mount Sinai Medical Center, New York, NY.
Urol Oncol. 2015 Mar;33(3):149-54. doi: 10.1016/j.urolonc.2014.11.023. Epub 2015 Jan 7.
The fundamental responsibility of a journal editor is to assure that studies accepted for publication provide rigorous original scientific information and reviews that are considered important to the readership. The fundamental requirements of such reports from an editor's perspective include objectivity and transparency in each of the study design, implementation of investigation methods, acquisition of data, inclusive analysis and interpretation of results, appropriate application of statistical methods, presentation of outcomes in the context of a balanced and comprehensive review of relevant literature, and meaningful conclusions. In proceeding on these presumptions, editors then have the responsibility of obtaining rigorous, objective, and constructive reviews of these reports so that they can make an unbiased decision regarding their disposition. The fundamental objective in this is to enhance the ultimate scientific validity and value of the work if and when it is accepted for publication. Guidelines have been advanced by several organizations to identify how such editorial responsibilities can be fulfilled. These guidelines also pertain to investigators, authors, and sponsors of the studies, which the various reports and reviews describe. The present article reviews these guidelines as they relate to both industry-sponsored and investigator-initiated investigations and as relevant to the variety of reports that a scientific/medical journal such as Urologic Oncology: Seminars and Original Investigations receives for publication.
期刊编辑的基本职责是确保被接受发表的研究提供严谨的原创科学信息以及对读者而言具有重要意义的综述。从编辑的角度来看，此类报告的基本要求包括研究设计、调查方法的实施、数据采集、结果的全面分析与解读、统计方法的恰当应用、在对相关文献进行平衡且全面综述的背景下呈现研究结果以及得出有意义的结论等各个方面的客观性和透明度。基于这些假设，编辑有责任对这些报告进行严谨、客观且具建设性的评审，以便能够就报告的处理做出公正的决定。这样做的根本目的是在研究被接受发表时提高其最终的科学有效性和价值。多个组织已经提出了指导方针，以明确如何履行此类编辑职责。这些指导方针也适用于各项报告和综述中所描述的研究的研究者、作者及资助者。本文将对这些指导方针进行综述，这些方针涉及行业资助研究和研究者发起的研究，以及与《泌尿肿瘤学：研讨会与原创研究》这类科学/医学期刊收到的用于发表的各类报告相关的内容。
